跳至主要内容
临床试验/JPRN-UMIN000006794
JPRN-UMIN000006794已完成未知

Genotype-Based Warfarin Therapy (GENWAT) study - Genotype-Based Warfarin Therapy (GENWAT) study

RIKE0 个研究点目标入组 1,000 人开始时间: 2011年12月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with a history of hypersensitivity to warfarin 2) Pregnancy and lactation patients 3) Patients with severe renal failure (serum creatinine>=2.5 mg/dL, patients on hemodialysis) 4) Patients with cirrhosis 5) Patients with hypoproteinemia (serum albumin<=2.5 g/dL) 6) Patients who require special attention for dosage adjustment 7) Patients with bleeding and who are potentially bleeding 8) Patient who are incapable to understand the contents of this study and will not give informed consent 9) Patients who participate in other clinical studies 10) Patients judged by investigators as ineligible for study enrollment 11) Patients who require invasive treatment during this study

研究者

发起方
RIKE

相似试验